KYORIN Signs Joint Development and License Agreement for Geojoカジノtically modified Adipocyte, Treatment Agent for Fabry Disease
Juojoカジノ 17, 2022
Please see the PDF file below for details.
Juojoカジノ 17, 2022
Please see the PDF file below for details.